Home・Elenco Azioni・West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Chiusa

SettoreSettore sanitario

348.47 0.18

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

340.33

Massimo

349.24

Metriche Chiave
By Trading Economics
Entrata	15M 154M
Vendite	27M 872M
P/E Media del settore	42.414 64.641
EPS	2.37
Rendimento da dividendi	0.27
Margine di Profitto	17.654
Dipendenti	10,800
EBITDA	-39M 179M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+18.42% upside

Dividendi
By Acuity
Rendimento da dividendi Media del settore	0.27% 2.31%
Utili prossimi	22 ott 2026
Prossima data del Dividendo	5 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-1.6B 23B
Apertura precedente	348.29
Chiusura precedente	348.47

Notizie sul Sentiment di mercato

By Acuity

50%

132 / 340 Classifica in Healthcare

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

31 lug 2026, 23:01 UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

29 lug 2026, 19:44 UTC

Macro Event

West Pharmaceutical Services is slightly lower amid broader market declines following the Federal Reserve's decision to keep interest rates steady.

28 lug 2026, 23:31 UTC

West Pharmaceutical Services shares declined in after-market trading, tracking broader market losses amid rising competition in the semiconductor sector.

27 lug 2026, 19:41 UTC

News

Evercore ISI raised its price target on West Pharmaceutical Services to $425, contributing to positive sentiment as shares trade higher since Friday's close.

24 lug 2026, 22:01 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours, continuing a trend of recent declines despite earlier volatility during the session.

22 lug 2026, 22:51 UTC

West Pharmaceutical Services Inc shares are trading higher in after-market hours, supported by strong performance relative to their 20-day moving average and one-month range.

21 lug 2026, 19:46 UTC

News

West Pharmaceutical Services has secured long-term agreements with Daikyo Seiko, enhancing its global reach. Shares are trading higher amid positive market momentum.

20 lug 2026, 19:16 UTC

West Pharmaceutical Services is lower today, influenced by a notable decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

18.42% in crescita

Previsioni per 12 mesi

Media 403.78 USD 18.42%

Alto 447 USD

Basso 365 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

10 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 10 che hanno fornito valutazioni azionarie a West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

132 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.